Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel E Feldstein

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Gastroenterology|June 16, 2009
Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver diseaseNaim Alkhouri, Rocio Lopez, Michael Berk, et al.
Frontiers in Cell and Developmental Biology|October 31, 2024
Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitisChristian Stoess, Aleksandra Leszczynska, Lin Kui, et al.
Frontiers in Cell and Developmental Biology|September 4, 2023
Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitisChristian Stoess, Aleksandra Leszczynska, Lin Kui, et al.
Clinics in Liver Disease|November 27, 2013
Obesity, nutrition, and liver disease in childrenAriel E Feldstein, Dana Patton-Ku, Kerri N Boutelle
Expert Opinion on Therapeutic Targets|April 23, 2013
Novel therapeutic targets for nonalcoholic fatty liver diseaseAkiko Eguchi, Davide Povero, Naim Alkhouri, et al.
The American Journal of Gastroenterology|January 8, 2008
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatmentChristine Carter-Kent, Nizar N Zein, Ariel E Feldstein
Metabolism: Clinical and Experimental|March 11, 2016
Similarities and differences between pediatric and adult nonalcoholic fatty liver diseaseMaricruz Crespo, Sara Lappe, Ariel E Feldstein, et al.
Seminars in Liver Disease|June 9, 2021
Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic ImplicationsBenedikt Kaufmann, Agustina Reca, Andrea D Kim, et al.
Digestive Diseases and Sciences|February 5, 2016
Innate Immunity and Inflammation in NAFLD/NASHMarco Arrese, Daniel Cabrera, Alexis M Kalergis, et al.
Clinical Lipidology|December 14, 2011
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Christine Carter-Kent, Michael Elias, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Gastroenterology|June 16, 2009
Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver diseaseNaim Alkhouri, Rocio Lopez, Michael Berk, et al.
Frontiers in Cell and Developmental Biology|October 31, 2024
Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitisChristian Stoess, Aleksandra Leszczynska, Lin Kui, et al.
Frontiers in Cell and Developmental Biology|September 4, 2023
Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitisChristian Stoess, Aleksandra Leszczynska, Lin Kui, et al.
Clinics in Liver Disease|November 27, 2013
Obesity, nutrition, and liver disease in childrenAriel E Feldstein, Dana Patton-Ku, Kerri N Boutelle
Expert Opinion on Therapeutic Targets|April 23, 2013
Novel therapeutic targets for nonalcoholic fatty liver diseaseAkiko Eguchi, Davide Povero, Naim Alkhouri, et al.
The American Journal of Gastroenterology|January 8, 2008
Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatmentChristine Carter-Kent, Nizar N Zein, Ariel E Feldstein
Metabolism: Clinical and Experimental|March 11, 2016
Similarities and differences between pediatric and adult nonalcoholic fatty liver diseaseMaricruz Crespo, Sara Lappe, Ariel E Feldstein, et al.
Seminars in Liver Disease|June 9, 2021
Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic ImplicationsBenedikt Kaufmann, Agustina Reca, Andrea D Kim, et al.
Digestive Diseases and Sciences|February 5, 2016
Innate Immunity and Inflammation in NAFLD/NASHMarco Arrese, Daniel Cabrera, Alexis M Kalergis, et al.
Clinical Lipidology|December 14, 2011
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver diseaseNaim Alkhouri, Christine Carter-Kent, Michael Elias, et al.
Pageof 19